European Patent Office

T 3122/19 (FGFR3 fusion gene/CHUGAI SEIYAKU KABUSHIKI) du 14.09.2023

Identifiant européen de la jurisprudence
ECLI:EP:BA:2023:T312219.20230914
Date de la décision
14 septembre 2023
Numéro de l'affaire
T 3122/19
Requête en révision de
-
Numéro de la demande
13842962.6
Langue de la procédure
Anglais
Distribution
Non distribuées (D)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
FGFR3 fusion gene and pharmaceutical drug targeting same
Nom du demandeur
Chugai Seiyaku Kabushiki Kaisha
Nom de l'opposant
Murphy, Colm Damien
Chambre
3.3.04
Sommaire
-
Dispositions juridiques pertinentes
European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 89Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Mots-clés
Main request - novelty (no)
Auxiliary request 1 - priority, inventive step (no)
Auxiliary request 2 - added matter (no), priority, novelty, inventive step, sufficiency of disclosure (yes)
Late-filed evidence - admitted in first-instance proceedings (no)
Late-filed evidence - should have been submitted in first-instance proceedings (yes)
Amendment after summons - cogent reasons (no)
Exergue
-
Affaires citantes
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent in amended form according to the claims of auxiliary request 2, filed as auxiliary request 4 with the patent proprietor's statement setting out the grounds of appeal, and a description and drawings possibly adapted thereto.